Cyclin-Dependent Kinase 4
specificCyclin-dependent kinase 4 (303 aa, ~34 kDa) is encoded by the human CDK4 gene. This protein may be involved in cell cycle regulation.
17
Centers
13
Active Trials
$6M
Cancer Funding
Top Centers for Cyclin-Dependent Kinase 4(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 54.1 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 54.1 |
| 3 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 54.1 |
| 4 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.1 |
| 5 | NCI Clinical Active Research Program | 54.1 |
| 6 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 54.1 |
| 7 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 54.1 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 54.1 |
| 9 | Active Research Program | 54.1 |
| 10 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 54.1 |
| 11 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 54.1 |
| 12 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 54.1 |
| 13 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 54.1 |
| 14 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 52.2 |
| 15 | NCI Comprehensive Active Research Program | 50.1 |
| 16 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 48.1 |
| 17 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 46.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →